Meanwhile, in vitro knockdown of FGFR1 by siRNA activated ROCK2, leading to endothelial dysfunction with increased adhesive properties and permeability in TNFα-treated HUVECs. The gene discussed is FGFR1; the disease is endothelial dysfunction.